Ask HopeStage to review this study with me
Study ID: NCT07618611. We help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07618611
Stellate ganglion block for PTSD
This study is not yet recruiting in Israel. It is testing stellate ganglion block for PTSD.
PTSDBehavioralFrom 18 Years to 99 Years
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Israel · 1 site
- Meir Medical CenterKfar SabaSite status: Not listed — confirm with the team
Key information made simple
What is this study testing?
This study is testing whether a blood test or biomarker may be useful for adults experiencing ptsd.
What would participation involve?
Participants may complete a blood test or biomarker, attend study visits with the research team. The registry lists locations in Israel.
Who is it mainly for?
This study appears to be mainly for adults with ptsd.
What should you check before joining?
Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateEstimated: August 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- sara dichtwald
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- PROCEDURE
- Study phase
- Not clearly listed
- Locations
- Israel
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT07618611
- Official title
- Dentification of Physiological Sleep Indices That Reflect Clinical Improvement and Reduction in Stress Biomarkers After Stellate Ganglion Block in Patients With Posttraumatic Stress Disorder (PTSD)
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT07618611. We help you review the study, but cannot decide medical eligibility.
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
Based on the public registry summary, this study is trying to understand: Post-traumatic stress disorder (PTSD) is a chronic disorder that develops following exposure to trauma, and is characterized by intrusive experiences, avoidance, cognitive-emotional changes, and hyperarousal. It is based on a complex noradrenergic dysregulation. The amygdala. The study team can confirm the exact objective and what it means for you.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study involving Stellate ganglion block. Phase is mainly useful to check for medication studies and some device studies.
Who might this study be for?
This study may concern people with ptsd; age range: From 18 Years to 99 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Will I need to change, stop, or stabilize my current treatment?
The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by sara dichtwald, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not Yet RecruitingNCT06710145
The Effect of Using the Combat Attention App on the Risk of Post-traumatic Symptoms
This study is not yet recruiting. It focuses on PTSD and currently lists study information in Israel.
RecruitingNCT06943560
Emotion Regulation Selection Flexibility Training for PTSD Patients
This study is recruiting. It focuses on PTSD and currently lists participation information in Israel.
RecruitingNCT06394284
Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury
The registry lists this study as recruiting. Study locations are listed in Israel. Confirm recruitment at each site. It focuses on PTSD.